We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Alvotech Countersues AbbVie, Seeking to Invalidate Humira Patents
Alvotech Countersues AbbVie, Seeking to Invalidate Humira Patents
Iceland-based biosimilar developer Alvotech has sued AbbVie in a U.S. federal court, seeking to have AbbVie’s patents for its blockbuster arthritis drug Humira (adalimumab) declared invalid.